Literature DB >> 12175432

Cost of medical injury in New Zealand: a retrospective cohort study.

Paul Brown1, Colin McArthur, Lynette Newby, Roy Lay-Yee, Peter Davis, Robin Briant.   

Abstract

OBJECTIVE: To estimate the cost of treating medical injury associated with hospital admissions in New Zealand and the patient characteristics of costly adverse events.
METHODS: As part of the New Zealand Quality in Healthcare Study (NZQHS), a retrospective examination of medical records in 13 public hospitals identified the occurrence of clinical procedures and hospital bed days attributable to adverse events. The prices charged to foreign patients were used to estimate the cost of the health care resources used.
RESULTS: 850 adverse events were identified in the NZQHS which cost an average of $NZ 10,264 per patient. For New Zealand, adverse events are estimated to cost the medical system $NZ 870 million, of which $NZ 590 million went toward treating preventable adverse events. The results suggest that up to 30% of public hospital expenditure goes toward treating an adverse event. The results also suggest that older patients, neonates and those with moderately serious co-morbidity tended to have more costly adverse events.
CONCLUSIONS: Adverse events lead to a significant use of health care resources in New Zealand. These findings suggest that substantial resources could be saved by eliminating preventable adverse events.

Entities:  

Mesh:

Year:  2002        PMID: 12175432     DOI: 10.1258/135581902320176449

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  4 in total

1.  Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions.

Authors:  Nazanin Falconer; Doreen Liow; Irene Zeng; Nirasha Parsotam; Mary Seddon; Sanjoy Nand
Journal:  Eur J Hosp Pharm       Date:  2017-05-16

2.  A Systematic Review of Methods for Medical Record Analysis to Detect Adverse Events in Hospitalized Patients.

Authors:  Dorthe O Klein; Roger J M W Rennenberg; Richard P Koopmans; Martin H Prins
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.243

3.  Estimating the incidence of adverse events in Portuguese hospitals: a contribution to improving quality and patient safety.

Authors:  Paulo Sousa; António Sousa Uva; Florentino Serranheira; Carla Nunes; Ema S Leite
Journal:  BMC Health Serv Res       Date:  2014-07-18       Impact factor: 2.655

4.  Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design.

Authors:  Jesus Maria Aranaz Andrés; Ramon Limón Ramírez; Carlos Aibar Remón; Maria Teresa Gea-Velázquez de Castro; Francisco Bolúmar; Ildefonso Hernández-Aguado; Nieves López Fresneña; Cristina Díaz-Agero Pérez; Enrique Terol García; Philippe Michel; Paulo Sousa; Itziar Larizgoitia Jauregui
Journal:  BMJ Open       Date:  2017-10-08       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.